ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
헬스케어 CRO 서비스 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 955억 7,000만 달러에 이르고, CAGR은 9.4%를 나타낼 전망입니다. 예측기간의 성장은 생물제제와 세포 및 유전자 치료의 대두, 희귀 질환에 대한 집중 증가, 비용효과와 속도의 중시, 실제 데이터에 대한 수요의 증가, 환자 중심주의의 중시, 바이오의약품 파이프라인의 성장 등에 기인한다고 생각됩니다. 예측기간의 주요 동향으로는 인공지능(AI)의 통합, 머신러닝(ML)의 통합, 환경, 사회, 거버넌스(ESG)에 대한 배려, 제약기업에 의한 R&D 투자 증가 등을 들 수 있습니다.
향후 5년간의 성장률 9.4%라고 하는 예측은 전회 예측으로부터 0.1%의 소폭 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 무역 마찰은 인도와 폴란드에서 개발된 해양 임상 검사 관리 및 약사 신청 서비스의 가격을 상승시키고, 의약품 개발 일정 지연 및 의약품 연구개발(R&D) 비용 상승을 초래하여 미국의 임상 연구를 저해할 수 있습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향이 보다 광범위하게 이어질 수 있습니다.
헬스케어 CRO 서비스 시장의 성장을 견인하는 것은 헬스케어 지출 증가입니다. 건강 관리 지출에는 의료 서비스, 가족 계획, 영양 프로그램, 응급 건강 지원 등의 제공과 관련된 모든 비용이 포함됩니다. 건강 관리 지출이 증가하면 의료 연구 개발을 위한 자금이 증가하고, 특히 임상 검사 및 연구를 지원하는 헬스케어 CRO 서비스에 대한 수요가 높아집니다. 예를 들어, 영국의 국가 통계 기관인 Office for National Statistics는 2022년 영국의 의료 지출이 약 3,548억 8,000만 달러(2,830억 파운드)에 이르렀고, 2021년에 비해 명목으로 0.7% 증가했다고 보고했습니다. 그 결과, 헬스케어 지출 증가는 헬스케어 CRO 서비스 시장의 확대에 기여하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 헬스케어 CRO 서비스 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 헬스케어 CRO 서비스 시장 : 성장률 분석
세계의 헬스케어 CRO 서비스 시장 실적: 규모와 성장, 2019-2024년
세계의 헬스케어 CRO 서비스 시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계의 헬스케어 CRO 서비스 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 헬스케어 CRO 서비스 시장 : 서비스 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
초기 개발 단계
임상 개발 서비스
실험실 서비스
컨설팅 서비스
세계의 헬스케어 CRO 서비스 시장 : 치유 영역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
종양학
중추 신경계 장애
심혈관 질환
대사성 질환
감염증
당뇨병
기타
세계의 헬스케어 CRO 서비스 시장 : 최종사용자별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
제약회사
의료기기 기업
학술기관
세계의 헬스케어 CRO 서비스 시장 : 초기 개발 단계별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
전임상 연구
페이즈 I 검사
배합 개발
세계의 헬스케어 CRO 서비스 시장 : 임상 개발 서비스별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
2단계 검사
3단계 검사
환자의 모집과 유지
사이트 관리
세계의 헬스케어 CRO 서비스 시장 : 실험실 서비스별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
생체분석검사
임상 검사 서비스
안전성 및 독성 검사
세계의 헬스케어 CRO 서비스 시장 : 컨설팅 서비스별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
규제 관련 업무 컨설팅
시장 접근 및 상업화
전략 계획과 실현 가능성 조사
제7장 지역별/국가별 분석
세계의 헬스케어 CRO 서비스 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 헬스케어 CRO 서비스 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
헬스케어 CRO 서비스 시장 : 경쟁 구도
헬스케어 CRO 서비스 시장 : 기업 프로파일
Laboratory Corporation of America Holdings.
IQVIA Inc.
Icon Plc.
PPD Inc.
Wuxi Apptec Co. Ltd.
제31장 기타 주요 기업 및 혁신 기업
Syneos Health Inc.
Parexel International Corporation
Charles River Laboratories International Inc.
Covance Inc.
Medpace Inc.
Pharmaron Beijing Co. Ltd.
BioClinica Inc.
Chiltern International Ltd.
Evotec SE
PSI CRO AG
Premier Research Group Ltd.
Worldwide Clinical Trials Inc.
Caidya
BioTelemetry Inc.
Syngene International Limited
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 전략
헬스케어 CRO 서비스 시장, 2029년 : 새로운 기회를 제공하는 국가
헬스케어 CRO 서비스 시장, 2029년 : 새로운 기회를 제공하는 부문
헬스케어 CRO 서비스 시장, 2029년 : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제36장 부록
SHW
영문 목차
영문목차
Healthcare Contract Research Organization (CRO) services encompass the outsourced support and specialized expertise provided to the pharmaceutical, biotechnology, and medical device sectors by dedicated businesses. These entities seek assistance from contract research organizations for a range of research-related tasks, including data management, conducting clinical trials, and preparing regulatory submissions.
The primary categories of healthcare CRO services include early-phase development, clinical development services, laboratory services, and consulting services. Early-phase development denotes the initial stage of a project or enterprise, involving the investigation, testing, and validation of theories or hypotheses to establish the foundation for future development and progress. These services find application in various therapeutic areas such as oncology, CNS disorders, cardiovascular diseases, metabolic diseases, infectious diseases, diabetes, and others. Multiple end-users, including pharmaceutical companies, medical device companies, and academic institutes, engage in the utilization of these services.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The healthcare CRO services market research report is one of a series of new reports from The Business Research Company that provides healthcare CRO services market statistics, including healthcare CRO services industry global market size, regional shares, competitors with a healthcare CRO services market share, detailed healthcare CRO services market segments, market trends and opportunities, and any further data you may need to thrive in the healthcare CRO services industry. This healthcare CRO services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The healthcare cro services market size has grown strongly in recent years. It will grow from $62.01 billion in 2024 to $66.77 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to increased focus on regulatory and medical affairs services by CROs, globalization of clinical trials, growing complexity of clinical trials, digital transformation in clinical trials, increased chronic diseases.
The healthcare cro services market size is expected to see strong growth in the next few years. It will grow to $95.57 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to rise of biologics and cell and gene therapies, increased focus on rare diseases, focus on cost-effectiveness and speed, growing demand for real-world data, focus on patient-centricity, biopharmaceutical pipeline growth. Major trends in the forecast period include integration of artificial intelligence (AI), integration of machine learning (ml), environmental, social, and governance (ESG) considerations, rising R&D investments by pharmaceutical companies.
The forecast of 9.4% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. clinical research by inflating prices of offshore clinical trial management and regulatory submission services developed in India and Poland, resulting in delayed drug development timelines and higher pharmaceutical research and development (R&D) costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The growth of the healthcare CRO services market is being driven by the increase in healthcare expenditures. Healthcare expenditures encompass all costs related to providing health services, family planning, nutrition programs, and emergency health assistance. As healthcare spending rises, it enables a larger pool of funding for medical research and development, which in turn boosts the demand for healthcare CRO services, particularly in supporting clinical trials and studies. For example, in 2022, the Office for National Statistics, a UK-based national statistics organization, reported that healthcare spending in the UK reached approximately $354.88 billion (£283 billion), marking a nominal increase of 0.7% compared to 2021. Consequently, the rise in healthcare spending is contributing to the expansion of the healthcare CRO services market.
The increasing number of clinical trials is expected to further boost the growth of the healthcare CRO services market. Clinical trials are scientific studies involving human participants designed to assess the safety and effectiveness of new medical interventions, such as drugs, therapies, devices, or procedures. Contract research organizations (CROs) play a vital role in the clinical trial process by providing various services that assist pharmaceutical and biotechnology companies in designing, conducting, and managing their studies efficiently. For instance, according to a report from Xtalks, a Canada-based web news and information network, there were 452,604 clinical studies registered on ClinicalTrials.gov as of May 2023, representing a significant increase from the over 365,000 registered trials recorded in early 2021. Therefore, the growth in clinical trials is contributing to the expansion of the healthcare CRO services market.
Major players in the healthcare CRO services market are adopting a strategic partnership approach to provide advanced Proteomics CRO services to biopharmaceutical and biomarker clients on a global scale. Strategic partnerships involve companies leveraging each other's strengths and resources for mutual benefits and success. In January 2023, Bruker Corporation, a US-based manufacturer of scientific instruments, formed a partnership with Biognosys AG, a Switzerland-based healthcare CRO services provider. The collaboration between Bruker and Biognosys is expected to create unique synergies, combining Biognosys' extensive range of proprietary proteomics services, software, and kits with Bruker's innovative timsTOF platform. This strategic partnership will result in the establishment of Biognosys' inaugural laboratory for advanced proteomics CRO services in the United States.
Major companies in the healthcare CRO services market are also innovating by developing products such as clinical trial monitoring solutions to expand their customer bases, boost sales, and increase revenue. A clinical trial monitoring solution is a comprehensive system or set of tools designed to oversee and manage various aspects of clinical trials. For example, in April 2022, Tata Consultancy Services (TCS), an India-based information technology (IT) services and consulting company, introduced a Risk-Based Monitoring solution. This innovative solution utilizes advanced statistical algorithms to proactively identify and address study and site risks in biopharmaceutical and Contract Research Organizations (CROs). Using data science, the solution accurately predicts outcomes related to site workload and risks, enabling stakeholders to implement informed monitoring strategies. The Risk-Based Monitoring solution provides unprecedented insights into missing data, enhancing data quality, consistency, and early detection of trends. With the potential for up to a 30% efficiency gain in site monitoring, the solution's automation streamlines processes, reduces site workload, ensures compliance, and accelerates product speed-to-market.
In May 2023, Elliott Investment Management L.P., a US-based investment management firm, along with Patient Square Capital, a US-based capital market company, and Veritas Capital Fund Management LLC, a US-based quantitative and systematic asset management firm, acquired Syneos Health Inc. for $7.1 billion. Through this acquisition, the consortium of private investment firms seeks to enhance its portfolio by leveraging Syneos Health's expertise in healthcare contract research organization (CRO) services. Syneos Health Inc. is a US-based company specializing in providing CRO services to the healthcare industry.
Major companies operating in the healthcare CRO services market include Laboratory Corporation of America Holdings., IQVIA Inc., Icon Plc., PPD Inc., Wuxi Apptec Co. Ltd., Syneos Health Inc., Parexel International Corporation, Charles River Laboratories International Inc., Covance Inc., Medpace Inc., Pharmaron Beijing Co. Ltd., BioClinica Inc., Chiltern International Ltd., Evotec SE, PSI CRO AG, Premier Research Group Ltd., Worldwide Clinical Trials Inc., Caidya, BioTelemetry Inc., Syngene International Limited, Novotech CRO, Celerion, GVK Biosciences Private Limited, Synteract Inc., Veristat LLC., ACM Global Laboratories, ClinTec Luxembourg SA, Clinlogix LLC
North America was the largest region in the healthcare CRO services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the healthcare cro services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the healthcare cro services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The healthcare CRO services market includes revenues earned by entities by providing services such as discovery studies, pre-clinical services, analytical testing, and related pharmacovigilance and drug safety, data management, and biostatistics. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Healthcare CRO Services Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on healthcare cro services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for healthcare cro services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The healthcare cro services market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Service Type: Early Phase Development; Clinical Development Services; Laboratory Services; Consulting Services
2) By Therapeutic Area: Oncology; CNS Disorder; Cardiovascular Disease; Metabolic Disease; Infectious Disease; Diabetes; Other Therapeutic Areas
3) By End User: Pharmaceutical Companies; Medical Device Companies; Academic Institutes
Subsegments:
1) By Early Phase Development: Preclinical Studies; Phase I Trials; Formulation Development
2) By Clinical Development Services: Phase II Trials; Phase III Trials; Patient Recruitment And Retention; Site Management
3) By Laboratory Services: Bioanalytical Testing; Clinical Laboratory Services; Safety And Toxicology Testing
4) By Consulting Services: Regulatory Affairs Consulting; Market Access And Commercialization; Strategic Planning And Feasibility Studies
Companies Mentioned: Laboratory Corporation of America Holdings.; IQVIA Inc.; Icon Plc.; PPD Inc.; Wuxi Apptec Co. Ltd.; Syneos Health Inc.; Parexel International Corporation; Charles River Laboratories International Inc.; Covance Inc.; Medpace Inc.; Pharmaron Beijing Co. Ltd.; BioClinica Inc.; Chiltern International Ltd.; Evotec SE; PSI CRO AG; Premier Research Group Ltd.; Worldwide Clinical Trials Inc.; Caidya; BioTelemetry Inc.; Syngene International Limited; Novotech CRO; Celerion; GVK Biosciences Private Limited; Synteract Inc.; Veristat LLC.; ACM Global Laboratories; ClinTec Luxembourg SA; Clinlogix LLC
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Healthcare CRO Services Market Characteristics
3. Healthcare CRO Services Market Trends And Strategies
4. Healthcare CRO Services Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Healthcare CRO Services Growth Analysis And Strategic Analysis Framework
5.1. Global Healthcare CRO Services PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Healthcare CRO Services Market Growth Rate Analysis
5.4. Global Healthcare CRO Services Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Healthcare CRO Services Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Healthcare CRO Services Total Addressable Market (TAM)
6. Healthcare CRO Services Market Segmentation
6.1. Global Healthcare CRO Services Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Early Phase Development
Clinical Development Services
Laboratory Services
Consulting Services
6.2. Global Healthcare CRO Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology
CNS Disorder
Cardiovascular Disease
Metabolic Disease
Infectious Disease
Diabetes
Other Therapeutic Areas
6.3. Global Healthcare CRO Services Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical Companies
Medical Device Companies
Academic Institutes
6.4. Global Healthcare CRO Services Market, Sub-Segmentation Of Early Phase Development, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Preclinical Studies
Phase I Trials
Formulation Development
6.5. Global Healthcare CRO Services Market, Sub-Segmentation Of Clinical Development Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Phase II Trials
Phase III Trials
Patient Recruitment And Retention
Site Management
6.6. Global Healthcare CRO Services Market, Sub-Segmentation Of Laboratory Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bioanalytical Testing
Clinical Laboratory Services
Safety And Toxicology Testing
6.7. Global Healthcare CRO Services Market, Sub-Segmentation Of Consulting Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Regulatory Affairs Consulting
Market Access And Commercialization
Strategic Planning And Feasibility Studies
7. Healthcare CRO Services Market Regional And Country Analysis
7.1. Global Healthcare CRO Services Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Healthcare CRO Services Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
